ORAMED PHARMACEUTICALS INC. (ORMP) Operating cash flow 2016–2025
ORAMED PHARMACEUTICALS INC. (ORMP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$9.1MFY2025 · since FY2016: $4.7M → -$9.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.1M | -8.7% |
| FY2024 | -$8.4M | +18.3% |
| FY2023 | -$10.3M | +63.1% |
| FY2022 | -$27.9M | -31.8% |
| FY2021 | -$21.2M | -70.3% |
| FY2020 | -$12.4M | +3.9% |
| FY2019 | -$12.9M | +11.7% |
| FY2018 | -$14.7M | -151.4% |
| FY2017 | -$5.8M | -225.3% |
| FY2016 | $4.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ORMP financial trends
ORMP RevenueORMP Net incomeORMP Net marginORMP Gross profitORMP Gross marginORMP Operating incomeORMP Operating marginORMP Free cash flowORMP Capital expendituresORMP Return on equityORMP Stock buybacksORMP Dividends paidORMP Total assetsORMP Total liabilitiesORMP Shareholders’ equityORMP overview →